SCHEMBL21140296

SCHEMBL21140296

CCCCCCC(NC(=O)/C=C/c1ccc(O)cc1)C(=O)Oc1cc(O)cc2c1C(=O)CC(c1ccc(O)cc1)O2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 5/20 0.44
▸ ESR2 Q92731 5/20 0.44
▸ CYP3A4 P08684 3/20 0.44
▸ CYP19A1 P11511 3/20 0.44
▸ CYP1A1 P04798 2/20 0.44
▸ CYP1A2 P05177 2/20 0.44
▸ CYP1B1 Q16678 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ ALOX12 P18054 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ CA12 O43570 1/20 0.44
▸ SLCO2B1 O94956 1/20 0.44
▸ TTR P02766 1/20 0.44
▸ SHBG P04278 1/20 0.44
▸ CALM1 P0DP23 1/20 0.44
▸ AMY1A P0DUB6 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ HSD17B1 P14061 1/20 0.44
▸ AKR1B1 P15121 1/20 0.44
▸ CBR1 P16152 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21139367 0.87 ESR1 (0.44) ESR1ESR2CYP3A4CYP19A1CYP1A1
SCHEMBL21139365 0.74 CYP19A1 (0.56) ESR1ESR2CYP3A4CYP19A1CYP1A1
SCHEMBL21139371 0.72 NOX4 (0.49) CYP3A4CYP19A1CYP1A1CYP1A2CYP1B1
SCHEMBL379369 0.70 CYP19A1 (0.65) CYP3A4CYP19A1CYP1A1CYP1A2CYP1B1
SCHEMBL15732281 0.69 CYP19A1 (0.53) ESR1ESR2CYP3A4CYP19A1CYP1A1
SCHEMBL21139388 0.69 CYP19A1 (0.56) ESR1ESR2CYP3A4CYP19A1CYP1A1
SCHEMBL799649 0.69 TAS2R31 (0.72) ESR1ESR2CYP3A4CYP19A1CYP1A1
SCHEMBL30641776 0.69 TAS2R31 (0.72) ESR1ESR2CYP3A4CYP19A1CYP1A1
SCHEMBL773766 0.69 TAS2R31 (0.72) ESR1ESR2CYP3A4CYP19A1CYP1A1
SCHEMBL21139391 0.68 CYP19A1 (0.55) ESR1ESR2CYP3A4CYP19A1CYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019111265-A1 COMPOUNDS AND METHODS FOR TREATING CANCER SHARE GAL RESEARCH AND DEVELOPMENT LTD (IL) 2019-06-13 — — WO disclosed
Send feedback